We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Clues Found to Mystery of Gene Deserts

By Biotechdaily staff writers
Posted on 16 Jan 2005
Similar to the living deserts of the American Southwest, the so-called "gene deserts” in living organisms' DNA are swarming with activity; the hard part is knowing where to look for this activity. More...
A new map to the location of DNA snippets that are vital to biologic, medical, and evolutional studies for these gene deserts could emerge from this new research.

Gene deserts are long extended sections of DNA between what were once believed to have no biologic function, and were rejected as "junk DNA.” However, as researchers look further into the DNA's double helix, they are finding that many of these noncoding pieces actually play a significant role in regulating gene activity.

Previous studies have demonstrated that that gene deserts contain DNA sequences that can turn genes on and off significant distances along the DNA molecule. The same scientists, paradoxically, discovered that they were recently able to eliminate large amounts of gene desert DNA from lab mice with no perceptible effect on the animals. Many of the removed sequences are shared by mice and humans, and therefore may have no useful function in humans as well.

In trying to solve the paradox and to help scientists more easily find important segments among the immense stretches of DNA deserts, scientists from Lawrence Livermore (U.S.) National Laboratory (LLNL; Livermore, CA, USA), Lawrence Berkeley (U.S.) National Laboratory (LBNL; Berkeley, CA, USA), and the Pennsylvania State University (University Park, PA, USA) have designed computational tools to decode gene regulation by comparing the genomes of many different species. The investigators published their results in the December 9, 2004, online version of the journal Genome Research.

When they utilized the tools to compare the human genome with the recently sequenced chicken genome, they found that gene deserts fall into two distinct categories: those that remain comparatively constant throughout years of evolution, and those that experience considerable variation.

Investigators said there are many pieces of evidence that demonstrate that the stable desert areas, which are able to withstand genomic reshufflling and fend off encroachment by repetitive segments of junk DNA, are home to an amazingly large portion of the genome's noncoding regulatory elements.

"There are many indications that stable gene deserts represent treasure boxes of multiple gene regulatory elements, guarding the proper complex function of the flanking genes,” said Dr. Ivan Ovcharenko, a bioinformatics researchers at LLNL's Computation Directorate, who led the study.

The variable areas, however, which comprise approximately two-thirds of the gene deserts and as much as 20% of the whole three-billion-base-pair human genome, can be devoid of biologic function, suggesting that a considerable portion of the genome may not be necessary. "This information is very important for researchers looking for mutations leading to disease because it highlights large areas of the genome that are not likely to be involved in causing diseases,” added Dr. Ovcharenko.

Dr. Eddy Rubin, director of the U.S. Department of Energy's Joint Genome Institute (JGI; Walnut Creek, CA, USA), observed, "If you're a good hunter looking for genetic clues to disease, it might be a good idea to steer clear of regions that are devoid of critical functions or importance,” including those that were removed in the earlier mouse studies.




Related Links:
Lawrence Livermore National Laboratory
Lawrence Berkeley National Laboratory

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.